Medical Condition News

RSS

MAP to present LEVADEX data on migraine at 15th Congress of IHC

MAP Pharmaceuticals, Inc. today announced that LEVADEX orally inhaled migraine drug will be featured in four poster presentations, including one late-breaker presentation, at the 15th Congress of the International Headache Society (IHC) in Berlin, Germany on June 23-26, 2011.

23 Jun 2011

Leicester free public lecture aims to reduce mortality from abdominal aortic aneurysms

A free public lecture by a University of Leicester academic on Tuesday, 28 June will discuss recent advances to reduce mortality from aortic aneurysms.

23 Jun 2011

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

A treatment that has virtually no side effects has been found to be an effective weapon for fighting early-stage breast cancer, according to results of a clinical trial conducted at Loma Linda University Medical Center.

23 Jun 2011

Fat substituted snack foods may contribute to weight gain

Fat substitutes used in popular snack foods to help people control weight may have the opposite effect, according to Purdue University research.

23 Jun 2011

FDA releases new tobacco warning labels that emphasize "horror factor"

The labels, which represent the first change in these warnings in 25 years, are required under a federal law that was passed in 2009 and must be displayed on cigarette packaging and advertisements by September 2012.

23 Jun 2011

Scientists study degradation of toxic compound found in groundwater systems

Vinyl chloride is a cancer-causing compound formed from solvents in groundwater systems under anaerobic conditions. These solvents are used in many industrial applications around the world and often belong to the most encountered groundwater pollutants in industrialized countries.

23 Jun 2011

Positive results from Neurelis NRL-1 Phase I pharmacokinetic study on acute repetitive seizures

In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam achieved positive clinical results in a Phase I pharmacokinetic study.

23 Jun 2011

Los Alamos National Lab scientists win three R&D Magazine's 2011 awards

Los Alamos National Laboratory scientists have won three of R&D Magazine's 2011 R&D100 Awards. Recognized as the "Oscars of Invention" by the Chicago Tribune, these awards honor the top 100 proven technological advances of the past year.

23 Jun 2011

Insights into type I diabetes

A new signal pathway that renders the insulin-releasing beta cell more sensitive to high levels of blood glucose has been discovered by researchers at the Swedish medical university Karolinska Institutet. A second new study reveals a possible way to delay the disease by inhibiting a lipoprotein.

23 Jun 2011

FDA reveals graphic new cigarette warning labels

"Nearly a half-century after U.S. cigarette packs were emblazoned with their first, modest warning, 'Caution: Cigarette Smoking May be Hazardous to Your Health,' the Food and Drug Administration - at Congress' behest - is … requiring tobacco companies to print painful images, such as that of a man smoking through a hole in his throat or of a lip eroded by cancer and a mouthful of rotting teeth, right on their cigarette packs," the Philadelphia Inquirer reports.

23 Jun 2011

SNP identification may help predict patients’ susceptibility to postoperative nausea and vomiting

There are several anesthetic complications that may have a hereditary background, including postoperative nausea and vomiting (PONV). Past observations have shown PONV to occur in blood relatives as far back as two to three generations.

23 Jun 2011

New sAPPβ biomarker may identify people at risk of developing Alzheimer's

A new biomarker may help identify which people with mild memory deficits will go on to develop Alzheimer's disease, according to a new study published in the June 22, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Jun 2011

Study reveals 29% decline in bicycle-related head injuries after mandatory helmet laws

Bicycle-related head injuries fell significantly in the months after mandatory helmet legislation came into effect in NSW, and recent calls for a repeal of the laws should be rejected, new research based on hospital admissions data shows.

23 Jun 2011

St. Jude Medical announces results of Genesis neurostimulator trial on chronic migraine

St. Jude Medical, Inc., a global medical device company, today announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide.

23 Jun 2011

MEDA seeks marketing authorization for Zyclara in Europe

“Zyclara will strengthen Meda's dermatology franchise in Europe. We look forward to provide AK patients with a new product that can treat larger areas of the skin”

23 Jun 2011

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

Diamyd Medical AB reports that the Company has decided to suspend dosing in a US Phase III study with the antigen-based therapy Diamyd and to initiate closure of the study.

23 Jun 2011

Unraveling molecular dysfunction due to environmental toxin exposure

In a new article published in the journal Molecular Neurodegeneration, researchers at the University of Missouri School of Medicine take some of the first steps toward unraveling the molecular dysfunction that occurs when proteins are exposed to environmental toxins. Their discovery helps further explain recent NIH findings that demonstrate the link between Parkinson's disease and two particular pesticides - rotenone and paraquat.

23 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research.

23 Jun 2011

New surprising details about flow of neurotransmitters between brain neurons

Two studies featuring research from Weill Cornell Medical College have uncovered surprising details about the complex process that leads to the flow of neurotransmitters between brain neurons -- a dance of chemical messages so delicate that missteps often lead to neurological dysfunction.

23 Jun 2011

Axxam receives ADDF grant to develop new therapeutics for Alzheimer's

The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation.

23 Jun 2011